Omega Healthcare price target raised to $33 from $29 at Truist

Truist analyst Michael Lewis raised the firm’s price target on Omega Healthcare to $33 from $29 and keeps a Hold rating on the shares after the company’s Q1 earnings beat reported last month. While the firm projects a return to earnings growth next year, the range of possible outcomes appears relatively wide as its projections are sensitive to assumptions regarding rent abatements and prospects for operators with tight rent coverage ratios, the analyst tells investors in a research note.